Managing attention-deficit/hyperactivity disorder in children and adolescents.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25634708.
- Also identified by DOI 10.1016/j.pop.2014.09.014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is the most frequently diagnosed neurodevelopmental disorder; 6.4 million children and adolescents have been diagnosed with ADHD as of 2011. However, only 3.5 million children and adolescents are taking medication for ADHD. Adolescents with ADHD are much less willing to pursue or adhere to medication or psychosocial therapy, often because of their perceptions of side effects or perceived value of treatment, which places them at greater risk for difficulties at school, work, and home environments. Providing adolescents with increased autonomy through patient-centered approaches can increase their involvement and ability to manage their ADHD symptoms and treatment.
Medical subject headings
- Adrenergic alpha-2 Receptor Agonists
- Attention Deficit Disorder with Hyperactivity
- Central Nervous System Stimulants